These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18695430)

  • 41. Heart failure assocated with pregabalin.
    Matsuki Y; Morikawa M; Nishimoto T; Yasuda Y; Shigemi K
    Pain Physician; 2012; 15(4):E536-7. PubMed ID: 22828703
    [No Abstract]   [Full Text] [Related]  

  • 42. Rash associated with pregabalin use.
    Smith TL; Baldwin A; Cunningham LL; Cook AM
    Ann Pharmacother; 2008 Dec; 42(12):1899-902. PubMed ID: 19001532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pregabalin for peripheral neuropathic pain: results of a multicenter, non-comparative, open-label study in Indian patients.
    LYRICA Study Group
    Int J Clin Pract; 2006 Sep; 60(9):1060-7. PubMed ID: 16939547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study.
    Gatti A; Sabato AF; Occhioni R; Colini Baldeschi G; Reale C
    Eur Neurol; 2009; 61(3):129-37. PubMed ID: 19092248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversible post-pregabalin peripheral edema in a spinal cord injury patient.
    Guzelkucuk U; Duman I; Yılmaz B; Tan AK
    Spinal Cord; 2012 Jun; 50(6):472-3. PubMed ID: 21747401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial.
    Stacey BR; Dworkin RH; Murphy K; Sharma U; Emir B; Griesing T
    Pain Med; 2008 Nov; 9(8):1202-8. PubMed ID: 18346060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of pregabalin in neuropathic pain treatment: a still unreported adverse effect.
    Masa-Vázquez LA; Villamil-Cajoto I; Villar Del Castillo A
    Minerva Med; 2008 Oct; 99(5):533-4. PubMed ID: 18971917
    [No Abstract]   [Full Text] [Related]  

  • 48. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief.
    Stacey BR; Barrett JA; Whalen E; Phillips KF; Rowbotham MC
    J Pain; 2008 Nov; 9(11):1006-17. PubMed ID: 18640074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of post-burn neuropathic pain: evaluation of pregablin.
    Wong L; Turner L
    Burns; 2010 Sep; 36(6):769-72. PubMed ID: 20362400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
    Richter RW; Portenoy R; Sharma U; Lamoreaux L; Bockbrader H; Knapp LE
    J Pain; 2005 Apr; 6(4):253-60. PubMed ID: 15820913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Gore M; Sadosky A; Tai KS; Stacey B
    Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pain quality response profile of pregabalin in the treatment of neuropathic pain.
    Jensen MP; Gammaitoni AR; Bolognese JA; Alon A; Smugar SS; Galer BS; Hewitt DJ
    Clin J Pain; 2012 Oct; 28(8):683-6. PubMed ID: 22156827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Costs and health resources utilization following switching to pregabalin in individuals with gabapentin-refractory neuropathic pain: a post hoc analysis.
    Navarro A; Saldaña MT; Pérez C; Masramón X; Rejas J
    Pain Pract; 2012 Jun; 12(5):382-93. PubMed ID: 22004531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pregabalin: new drug. Very similar to gabapentin.
    Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decompensation of chronic heart failure associated with pregabalin in a 73-year-old patient with postherpetic neuralgia: a case report.
    De Smedt RH; Jaarsma T; van den Broek SA; Haaijer-Ruskamp FM
    Br J Clin Pharmacol; 2008 Aug; 66(2):327-8. PubMed ID: 18507657
    [No Abstract]   [Full Text] [Related]  

  • 57. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
    Zhao Y; Sun P; Watson P
    Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pregabalin for peripheral neuropathic pain.
    Hadj Tahar A
    Issues Emerg Health Technol; 2005 Mar; (67):1-4. PubMed ID: 15806748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Should we care about pregabalin for elderly patients with a history of cardiac dysrhythmia?].
    Laville MA; de la Gastine B; Husson B; Le Boisselier R; Mosquet B; Coquerel A
    Rev Med Interne; 2008 Feb; 29(2):152-4. PubMed ID: 17976866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pregabalin (Lyrica) and neuropathic pain syndromes].
    Jacquy J; Lossignol D; Sternon J
    Rev Med Brux; 2006; 27(5):445-50. PubMed ID: 17144644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.